Jennifer Cook - Autonomix Medical Chief Officer
| AMIX Stock | 0.38 0.01 2.56% |
Executive
Jennifer Cook is Chief Officer of Autonomix Medical Common
| Address | 21 Waterway Avenue, The Woodlands, TX, United States, 77380 |
| Phone | 713 588 6150 |
| Web | https://autonomix.com |
Autonomix Medical Management Efficiency
The company has return on total asset (ROA) of (1.5931) % which means that it has lost $1.5931 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.5241) %, meaning that it created substantial loss on money invested by shareholders. Autonomix Medical's management efficiency ratios could be used to measure how well Autonomix Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -1.1 in 2026. Return On Capital Employed is likely to drop to -1.35 in 2026. Non Current Assets Total is likely to rise to about 237.9 K in 2026, whereas Total Assets are likely to drop slightly above 6.1 M in 2026.Similar Executives
| Showing other executives | EXECUTIVE Age | ||
| Ralph Cavalli | AIM ImmunoTech | 67 | |
| Deina Walsh | Bone Biologics Corp | 60 | |
| Robert IV | AIM ImmunoTech | 70 | |
| Christopher McAleer | AIM ImmunoTech | N/A | |
| Greg Gironda | Oragenics | N/A | |
| Josiah Craver | Kala Pharmaceuticals | N/A | |
| Stacy Salvi | Movano Inc | N/A | |
| Michael Soule | Movano Inc | N/A | |
| MD MA | Oragenics | N/A | |
| Francis MD | Kala Pharmaceuticals | N/A | |
| IV BA | AIM ImmunoTech | 69 | |
| Melissa Kang | Venus Concept | 59 | |
| Jesus AlvarezQuintero | Venus Concept | N/A | |
| MBA JD | Kala Pharmaceuticals | 46 | |
| Ross Portaro | Venus Concept | 63 | |
| Yoni Iger | Venus Concept | 65 | |
| Anna Georgiadis | Venus Concept | 55 | |
| Michael Mandarello | Venus Concept | 41 | |
| Jill Steier | Kala Pharmaceuticals | N/A | |
| Jason Raser | Venus Concept | N/A | |
| MD FACP | AIM ImmunoTech | N/A | |
Management Performance
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 |
Autonomix Medical Common Leadership Team
Elected by the shareholders, the Autonomix Medical's board of directors comprises two types of representatives: Autonomix Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Autonomix. The board's role is to monitor Autonomix Medical's management team and ensure that shareholders' interests are well served. Autonomix Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Autonomix Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Robert MD, CoFounder Officer | ||
| Landy Toth, CoFounder Officer | ||
| Jennifer Cook, Chief Officer | ||
| David Robins, CoFounder Director | ||
| Walter Klemp, Executive Chairman | ||
| Trent CPA, Chief Officer | ||
| Lori Bisson, Executive Chairman | ||
| Bradley Hauser, CEO President |
Autonomix Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Autonomix Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -3.52 | ||||
| Return On Asset | -1.59 | ||||
| Current Valuation | (8.02 M) | ||||
| Shares Outstanding | 6.91 M | ||||
| Shares Owned By Insiders | 6.71 % | ||||
| Shares Owned By Institutions | 5.42 % | ||||
| Number Of Shares Shorted | 579.65 K | ||||
| Price To Book | 0.41 X | ||||
| EBITDA | (11.05 M) | ||||
| Net Income | (11.41 M) |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Autonomix Stock Analysis
When running Autonomix Medical's price analysis, check to measure Autonomix Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Autonomix Medical is operating at the current time. Most of Autonomix Medical's value examination focuses on studying past and present price action to predict the probability of Autonomix Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Autonomix Medical's price. Additionally, you may evaluate how the addition of Autonomix Medical to your portfolios can decrease your overall portfolio volatility.